Integrated Biologix GmbH was founded by Dr Jennifer Sims in 2012 to provide non-clinical development support for Biopharmaceuticals. We provide fully integrated non-clinical development support for biopharmaceuticals at all stages of the drug-development cycle from target/candidate selection through IND/CTA and clinical development to approval and beyond. We can help you select the right candidate, design, interpret & communicate relevant and streamlined non-clinical development programs, to achieve successful regulatory approvals.

The company is a growing team of experts to provide an integrated service including PK/PD, bioanalysis, immunogenicity and non-clinical safety (toxicology, pathology & safety pharmacology). We provide integrated solutions with our close collaboration partner LYO-X GmbH. LYO-X is a modelling & simulation consultancy specialised in biologics and novel formats.

Integrated Biologix GmbH has over 80 clients including early start-ups, academic spin-outs and small and large biopharmaceutical companies. We can complement your in-house project teams ensuring a timely (right first time) and cost-efficient service.